{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:03:20Z","timestamp":1792494200807,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ccell.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T10:35:32Z","timestamp":1696502132000},"page":"1911-1926.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory"],"prefix":"10.1016","volume":"41","author":[{"given":"Iker","family":"Ausejo-Mauleon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Labiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"de la Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Laspidea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zalacain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Marrod\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Garc\u00eda-Moure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Gonz\u00e1lez-Huarriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irati","family":"Herv\u00e1s-Corpi\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laasya","family":"Dhandapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvestre","family":"Vicent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Collantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Pe\u00f1uelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren J.","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella G.","family":"Filbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Labelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.O.","family":"de Biagi-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Laternser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy N.","family":"Phoenix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"van der Lugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Kranendonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoull","family":"Hoogendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"De Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Guruceaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Koschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viveka Nand","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"G\u00e1llego P\u00e9rez-Larraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Pati\u00f1o-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta M.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2023.09.001_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: An international diffuse intrinsic pontine glioma registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib3","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","article-title":"Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A collaborative report from the International and European Society for Pediatric Oncology DIPG registries","volume":"36","author":"Hoffman","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2023.09.001_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11060-019-03287-9","article-title":"Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?","volume":"145","author":"El-Khouly","year":"2019","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cancergen.2015.04.008","article-title":"Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape","volume":"208","author":"Panditharatna","year":"2015","journal-title":"Cancer Genet."},{"key":"10.1016\/j.ccell.2023.09.001_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11060-018-2991-5","article-title":"Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience","volume":"140","author":"Kline","year":"2018","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","article-title":"Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma","volume":"6","author":"Lin","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ccell.2023.09.001_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/neuonc\/noy145","article-title":"Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy Key Points","volume":"21","author":"Lieberman","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ccell.2023.09.001_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.09.001_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-018-0713-7","article-title":"Blockade of TIM3 relieves immunosuppression through reducing regulatory T\u00a0cells in head and neck cancer","volume":"37","author":"Liu","year":"2018","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2023.09.001_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.imbio.2019.03.001","article-title":"Immunobiology NK cell expression of Tim-3 : First impressions matter","volume":"224","author":"So","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.ccell.2023.09.001_bib13","first-page":"3734","article-title":"Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity","volume":"119","author":"Ndhlovu","year":"2012"},{"key":"10.1016\/j.ccell.2023.09.001_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nmeth.2250","article-title":"Tumor-infiltrating DCs suppress nucleic acid\u2013mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1","volume":"10","author":"Fonslow","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2023.09.001_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","article-title":"TIM-3 restrains anti-tumour immunity by regulating inflammasome activation","volume":"595","author":"Dixon","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.09.001_bib16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/2326-6066.CIR-14-0156","article-title":"The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas","volume":"3","author":"Komohara","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2023.09.001_bib17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/cns.13100","article-title":"Negative regulation of glial Tim-3 inhibits the secretion of inflammatory factors and modulates microglia to antiinflammatory phenotype after experimental intracerebral hemorrhage in rats","volume":"25","author":"Chen","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ccell.2023.09.001_bib18","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1038\/ncomms7340","article-title":"The HIF-1\/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia","volume":"6","author":"Koh","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2023.09.001_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/sj.jid.5700616","article-title":"TIM-3 Is Expressed in Melanoma Cells and Is Upregulated in TGF-Beta Stimulated Mast Cells","volume":"127","author":"Wiener","year":"2007","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ccell.2023.09.001_bib20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3892\/ol.2013.1410","article-title":"TIM-3 expression in human osteosarcoma: Correlation with the expression of epithelial-mesenchymal transition-specific biomarkers","volume":"6","author":"Shang","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ccell.2023.09.001_bib21","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1158\/0008-5472.CAN-22-0970","article-title":"Inhibition of melanoma cell-intrinsic Tim-3 stimulates MAPK-dependent tumorigenesis","volume":"82","author":"Schatton","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2023.09.001_bib22","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1038\/s41388-018-0140-4","article-title":"Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-\u03baB\/IL-6\/STAT3 axis","volume":"37","author":"Zhang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2023.09.001_bib23","doi-asserted-by":"crossref","first-page":"105329","DOI":"10.1016\/j.isci.2022.105329","article-title":"Cancer cell intrinsic TIM-3 induces glioblastoma progression","volume":"25","author":"Guo","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ccell.2023.09.001_bib24","first-page":"331","article-title":"Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq","volume":"360","author":"Filbin","year":"2018","journal-title":"Science (1979)"},{"key":"10.1016\/j.ccell.2023.09.001_bib25","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s41588-022-01236-3","article-title":"The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location","volume":"54","author":"Liu","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2023.09.001_bib26","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1172\/JCI133310","article-title":"Everolimus improves the efficacy of dasatinib in PDGFR\u03b1-driven glioma","volume":"130","author":"Miklja","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2023.09.001_bib27","article-title":"Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma","volume":"4","author":"Du Chatinier","year":"2022","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.ccell.2023.09.001_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12092064","article-title":"Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle","volume":"12","author":"Di Ruscio","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.ccell.2023.09.001_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fonc.2018.00239","article-title":"Beyond the blood: Brain barrier: The importance of central nervous system (CNS) pharmacokinetics for the treatment of CNS tumors, including diffuse intrinsic pontine glioma","volume":"8","author":"Warren","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib30","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","article-title":"Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma","volume":"386","author":"G\u00e1llego P\u00e9rez-Larraya","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2023.09.001_bib31","series-title":"Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-In-Human Bioactivity and Safety","author":"Vitanza","year":"2023"},{"key":"10.1016\/j.ccell.2023.09.001_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10147-020-01853-0","article-title":"Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults after radiotherapy","volume":"26","author":"Szychot","year":"2021","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3171\/2018.9.PEDS17225","article-title":"Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma","volume":"23","author":"Heiss","year":"2018","journal-title":"J.\u00a0Neurosurg. Pediatr."},{"key":"10.1016\/j.ccell.2023.09.001_bib34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2567.2011.03446.x","article-title":"CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells","volume":"133","author":"Fu","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.ccell.2023.09.001_bib35","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1038\/s41467-021-24347-7","article-title":"Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma","volume":"12","author":"van Hooren","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2023.09.001_bib36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/neuonc\/nox208","article-title":"Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: Results from exploratory phase i cohorts of CheckMate 143","volume":"20","author":"Omuro","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/neuonc\/noz185","article-title":"Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages","volume":"22","author":"De Groot","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11060-020-03448-1","article-title":"A review of glioblastoma immunotherapy","volume":"151","author":"Medikonda","year":"2021","journal-title":"J.\u00a0Neuro Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib39","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/neuonc\/noac117","article-title":"The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies","volume":"24","author":"Persson","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ccell.2023.09.001_bib40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T\u00a0cells in H3-K27M+ diffuse midline gliomas letter","volume":"24","author":"Mount","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2023.09.001_bib41","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/s41467-019-10043-0","article-title":"The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models","volume":"10","author":"Mart\u00ednez-V\u00e9lez","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2023.09.001_bib42","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154812","article-title":"Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas","volume":"7","author":"Laspidea","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ccell.2023.09.001_bib43","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","article-title":"GD2-CAR T\u00a0cell therapy for H3K27M-mutated diffuse midline gliomas","volume":"603","author":"Majzner","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.09.001_bib44","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1158\/1078-0432.CCR-19-3538","article-title":"Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma","volume":"26","author":"Meel","year":"2020","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.ccell.2023.09.001_bib45","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1158\/0008-5472.CAN-19-2834","article-title":"Glial TIM-3 modulates immune responses in the brain tumor microenvironment","volume":"80","author":"Kim","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2023.09.001_bib46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of General and Discriminating Markers of Differential Microglia Phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ccell.2023.09.001_bib47","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200785","article-title":"Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model","volume":"217","author":"Wang","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2023.09.001_bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41421-022-00377-3","article-title":"Distinct phases of adult microglia proliferation: a Myc-mediated early phase and a Tnfaip3-mediated late phase","volume":"8","author":"Tan","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.ccell.2023.09.001_bib49","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41593-018-0090-8","article-title":"Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion","volume":"21","author":"Huang","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ccell.2023.09.001_bib50","doi-asserted-by":"crossref","first-page":"108291","DOI":"10.1016\/j.celrep.2020.108291","article-title":"Dendritic Cells and Microglia Have Non-redundant Functions in the Inflamed Brain with Protective Effects of Type 1 cDCs","volume":"33","author":"Gallizioli","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2023.09.001_bib51","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3389\/fimmu.2020.00997","article-title":"CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy","volume":"11","author":"Joly-Amado","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2023.09.001_bib52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cellimm.2011.05.001","article-title":"CCL5 induces a pro-inflammatory profile in microglia in\u00a0vitro","volume":"270","author":"\u0160kuljec","year":"2011","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ccell.2023.09.001_bib53","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210108","article-title":"Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN\u2013driven CCL5 and CXCL10","volume":"218","author":"Mowat","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2023.09.001_bib54","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2023.09.001_bib55","doi-asserted-by":"crossref","first-page":"E4041","DOI":"10.1073\/pnas.1720948115","article-title":"Macrophages impede CD8 T\u00a0cells from reaching tumor cells and limit the efficacy of anti\u2013PD-1 treatment","volume":"115","author":"Peranzoni","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2023.09.001_bib56","doi-asserted-by":"crossref","first-page":"110021","DOI":"10.1016\/j.celrep.2021.110021","article-title":"Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade","volume":"37","author":"Wang","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2023.09.001_bib57","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610823003185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610823003185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:06:50Z","timestamp":1733789210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610823003185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1535610823003185"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2023.09.001","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}